Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Frontiers in Pediatrics|May 9, 2015
Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trialGabrielle B McCallum, Peter S Morris, Keith Grimwood, et al.
Vaccine|November 4, 2015
PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, AustraliaMichael J Binks, Sarah A Moberley, Anne Balloch, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External ValidationCristina Sanches, Geisa C S Alves, Andras Farkas, et al.
Vaccine: X|March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
Open Forum Infectious Diseases|August 16, 2021
Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase-Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)Adam G Stewart, David L Paterson, Barnaby Young, et al.
Plos One|August 23, 2013
L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trialAnna P Ralph, Govert Waramori, Gysje J Pontororing, et al.
Trials|September 4, 2012
Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trialAnne B Chang, Keith Grimwood, Colin F Robertson, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|July 1, 2018
Bacteria and viruses in the nasopharynx immediately prior to onset of acute lower respiratory infections in Indigenous Australian childrenHeidi C Smith-Vaughan, Michael J Binks, Jemima Beissbarth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2026
Empirical Antibiotic Activity and Outcomes in Pediatric Gram-Negative Bloodstream Infections: A Rank-based Composite Outcome AnalysisSophie C H Wen, Melissa J Hardy, Abdullah T Aslan, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Pageof 14